ID   GALT4_HUMAN             Reviewed;         578 AA.
AC   Q8N4A0; B2R775; B4DMX6; O00208;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 2.
DT   03-AUG-2022, entry version 154.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 4;
DE            EC=2.4.1.41 {ECO:0000269|PubMed:10984485, ECO:0000269|PubMed:29208955, ECO:0000269|PubMed:9804815};
DE   AltName: Full=Polypeptide GalNAc transferase 4;
DE            Short=GalNAc-T4 {ECO:0000303|PubMed:9804815};
DE            Short=pp-GaNTase 4;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 4;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4;
GN   Name=GALNT4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, PATHWAY,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND VARIANT ILE-506.
RX   PubMed=9804815; DOI=10.1074/jbc.273.46.30472;
RA   Bennett E.P., Hassan H., Mandel U., Mirgorodskaya E., Roepstorff P.,
RA   Burchell J., Taylor-Papadimitriou J., Hollingsworth M.A., Merkx G.,
RA   van Kessel A.G., Eiberg H., Steffensen R., Clausen H.;
RT   "Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-
RT   acetylgalactosaminyltransferase that complements other GalNAc-transferases
RT   in complete O-glycosylation of the MUC1 tandem repeat.";
RL   J. Biol. Chem. 273:30472-30481(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANTS
RP   THR-270 AND ILE-506.
RC   TISSUE=Kidney, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-51.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, DOMAIN, PATHWAY, AND MUTAGENESIS OF ASP-459.
RX   PubMed=10984485; DOI=10.1074/jbc.m005783200;
RA   Hassan H., Reis C.A., Bennett E.P., Mirgorodskaya E., Roepstorff P.,
RA   Hollingsworth M.A., Burchell J., Taylor-Papadimitriou J., Clausen H.;
RT   "The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-
RT   acetylgalactosaminyltransferase-T4 directs its glycopeptide
RT   specificities.";
RL   J. Biol. Chem. 275:38197-38205(2000).
RN   [6] {ECO:0007744|PDB:5NQA}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ANALOG,
RP   DOMAIN, CATALYTIC ACTIVITY, FUNCTION, PATHWAY, COFACTOR, AND DISULFIDE
RP   BONDS.
RX   PubMed=29208955; DOI=10.1038/s41467-017-02006-0;
RA   de Las Rivas M., Lira-Navarrete E., Daniel E.J.P., Companon I., Coelho H.,
RA   Diniz A., Jimenez-Barbero J., Peregrina J.M., Clausen H., Corzana F.,
RA   Marcelo F., Jimenez-Oses G., Gerken T.A., Hurtado-Guerrero R.;
RT   "The interdomain flexible linker of the polypeptide GalNAc transferases
RT   dictates their long-range glycosylation preferences.";
RL   Nat. Commun. 8:1959-1959(2017).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide
CC       biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a
CC       serine or threonine residue on the protein receptor. Has a highest
CC       activity toward Muc7, EA2 and Muc2, with a lowest activity than GALNT2.
CC       Glycosylates 'Thr-57' of SELPLG. {ECO:0000269|PubMed:10984485,
CC       ECO:0000269|PubMed:29208955, ECO:0000269|PubMed:9804815}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-O-
CC         [N-acetyl-alpha-D-galactosaminyl]-L-seryl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:23956, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12788,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:53604,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:67138; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:10984485, ECO:0000269|PubMed:29208955,
CC         ECO:0000269|PubMed:9804815};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-
CC         O-[N-acetyl-alpha-D-galactosaminyl]-L-threonyl-[protein] + H(+) +
CC         UDP; Xref=Rhea:RHEA:52424, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11689, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:67138, ChEBI:CHEBI:87075; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:10984485, ECO:0000269|PubMed:29208955,
CC         ECO:0000269|PubMed:9804815};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:29208955};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:10984485, ECO:0000269|PubMed:29208955,
CC       ECO:0000269|PubMed:9804815}.
CC   -!- INTERACTION:
CC       Q8N4A0; P42858: HTT; NbExp=12; IntAct=EBI-21555925, EBI-466029;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000305|PubMed:9804815}; Single-pass type II membrane protein
CC       {ECO:0000305|PubMed:9804815}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N4A0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N4A0-2; Sequence=VSP_045009, VSP_045010;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in mucous cells.
CC       {ECO:0000269|PubMed:9804815}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif), which
CC       is probably involved in manganese coordination and substrate binding
CC       and the C-terminal domain (domain B, also called Gal/GalNAc-T motif),
CC       which is probably involved in catalytic reaction and UDP-Gal binding.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain directs the glycopeptide
CC       specificity. It is required in the glycopeptide specificity of enzyme
CC       activity but not for activity with naked peptide substrates, suggesting
CC       that it triggers the catalytic domain to act on GalNAc-glycopeptide
CC       substrates. {ECO:0000269|PubMed:10984485, ECO:0000269|PubMed:29208955}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 4;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_486";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y08564; CAA69875.1; -; Genomic_DNA.
DR   EMBL; AK297677; BAG60038.1; -; mRNA.
DR   EMBL; AK312870; BAG35722.1; -; mRNA.
DR   EMBL; AC010201; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025034; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036390; AAH36390.1; -; mRNA.
DR   CCDS; CCDS53817.1; -. [Q8N4A0-1]
DR   RefSeq; NP_001186711.1; NM_001199782.1. [Q8N4A0-2]
DR   RefSeq; NP_003765.2; NM_003774.4. [Q8N4A0-1]
DR   PDB; 5NQA; X-ray; 1.90 A; A/B=1-578.
DR   PDB; 6H0B; X-ray; 1.80 A; A/B=1-578.
DR   PDBsum; 5NQA; -.
DR   PDBsum; 6H0B; -.
DR   AlphaFoldDB; Q8N4A0; -.
DR   SMR; Q8N4A0; -.
DR   BioGRID; 114240; 12.
DR   BioGRID; 1529357; 1.
DR   IntAct; Q8N4A0; 9.
DR   STRING; 9606.ENSP00000436604; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   UniLectin; Q8N4A0; -.
DR   GlyGen; Q8N4A0; 2 sites, 2 O-linked glycans (1 site).
DR   iPTMnet; Q8N4A0; -.
DR   PhosphoSitePlus; Q8N4A0; -.
DR   SwissPalm; Q8N4A0; -.
DR   BioMuta; GALNT4; -.
DR   DMDM; 338817878; -.
DR   EPD; Q8N4A0; -.
DR   jPOST; Q8N4A0; -.
DR   MassIVE; Q8N4A0; -.
DR   MaxQB; Q8N4A0; -.
DR   PaxDb; Q8N4A0; -.
DR   PeptideAtlas; Q8N4A0; -.
DR   PRIDE; Q8N4A0; -.
DR   ProteomicsDB; 71900; -. [Q8N4A0-1]
DR   Antibodypedia; 53055; 155 antibodies from 25 providers.
DR   DNASU; 8693; -.
DR   Ensembl; ENST00000529983.3; ENSP00000436604.2; ENSG00000257594.4. [Q8N4A0-1]
DR   GeneID; 100528030; -.
DR   GeneID; 8693; -.
DR   KEGG; hsa:100528030; -.
DR   KEGG; hsa:8693; -.
DR   MANE-Select; ENST00000529983.3; ENSP00000436604.2; NM_003774.5; NP_003765.2.
DR   UCSC; uc001tbd.4; human. [Q8N4A0-1]
DR   CTD; 100528030; -.
DR   CTD; 8693; -.
DR   DisGeNET; 100528030; -.
DR   DisGeNET; 8693; -.
DR   GeneCards; GALNT4; -.
DR   HGNC; HGNC:4126; GALNT4.
DR   HPA; ENSG00000257594; Tissue enhanced (stomach).
DR   MalaCards; GALNT4; -.
DR   MIM; 603565; gene.
DR   neXtProt; NX_Q8N4A0; -.
DR   OpenTargets; ENSG00000257594; -.
DR   PharmGKB; PA28539; -.
DR   VEuPathDB; HostDB:ENSG00000257594; -.
DR   eggNOG; KOG3736; Eukaryota.
DR   GeneTree; ENSGT00940000163607; -.
DR   HOGENOM; CLU_013477_0_1_1; -.
DR   InParanoid; Q8N4A0; -.
DR   OMA; WHSVPKH; -.
DR   OrthoDB; 606683at2759; -.
DR   PhylomeDB; Q8N4A0; -.
DR   TreeFam; TF352660; -.
DR   BRENDA; 2.4.1.41; 2681.
DR   PathwayCommons; Q8N4A0; -.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   SignaLink; Q8N4A0; -.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 100528030; 32 hits in 956 CRISPR screens.
DR   BioGRID-ORCS; 8693; 8 hits in 1064 CRISPR screens.
DR   Pharos; Q8N4A0; Tbio.
DR   PRO; PR:Q8N4A0; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q8N4A0; protein.
DR   Bgee; ENSG00000257594; Expressed in endometrium and 101 other tissues.
DR   Genevisible; Q8N4A0; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IBA:GO_Central.
DR   GO; GO:0018242; P:protein O-linked glycosylation via serine; IDA:UniProtKB.
DR   GO; GO:0018243; P:protein O-linked glycosylation via threonine; IDA:UniProtKB.
DR   CDD; cd02510; pp-GalNAc-T; 1.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR045885; GalNAc-T.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Lectin; Manganese; Membrane;
KW   Metal-binding; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..578
FT                   /note="Polypeptide N-acetylgalactosaminyltransferase 4"
FT                   /id="PRO_0000059108"
FT   TOPO_DOM        1..12
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        13..35
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        36..578
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          444..577
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REGION          134..243
FT                   /note="Catalytic subdomain A"
FT   REGION          303..365
FT                   /note="Catalytic subdomain B"
FT   BINDING         175
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q10471"
FT   BINDING         204
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q10471"
FT   BINDING         227
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:Q10471"
FT   BINDING         229
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:Q10471"
FT   BINDING         334
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q10471"
FT   BINDING         362
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:Q10471"
FT   BINDING         370
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q10471"
FT   SITE            459
FT                   /note="Interaction with glycopeptide substrate"
FT                   /evidence="ECO:0000269|PubMed:29208955"
FT   SITE            478
FT                   /note="Interaction with glycopeptide substrate"
FT                   /evidence="ECO:0000269|PubMed:29208955"
FT   SITE            483
FT                   /note="Interaction with glycopeptide substrate"
FT                   /evidence="ECO:0000269|PubMed:29208955"
FT   CARBOHYD        471
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        124..357
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174,
FT                   ECO:0000269|PubMed:29208955, ECO:0007744|PDB:5NQA"
FT   DISULFID        348..421
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174,
FT                   ECO:0000269|PubMed:29208955, ECO:0007744|PDB:5NQA"
FT   DISULFID        457..477
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174,
FT                   ECO:0000269|PubMed:29208955, ECO:0007744|PDB:5NQA"
FT   DISULFID        503..518
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174,
FT                   ECO:0000269|PubMed:29208955, ECO:0007744|PDB:5NQA"
FT   DISULFID        547..565
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174,
FT                   ECO:0000269|PubMed:29208955, ECO:0007744|PDB:5NQA"
FT   VAR_SEQ         1..120
FT                   /note="MAVRWTWAGKSCLLLAFLTVAYIFVELLVSTFHASAGAGRARELGSRRLSDL
FT                   QKNTEDLSRPLYKKPPADSRALGEWGKASKLQLNEDELKQQEELIERYAINIYLSDRIS
FT                   LHRHIEDKR -> MAWCVATADPAHTSRPLFTGLAVSRGSAGHAWSAGFDWAAVVVVTG
FT                   RRCRSGQTVPGAARSPLLPHPLPSPLRVPPPTGALGRPLPRWPQPRRTPFWSVISKATK
FT                   LRSPPWTSAPTASNL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045009"
FT   VAR_SEQ         121..292
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045010"
FT   VARIANT         51
FT                   /note="D -> G (in dbSNP:rs17853610)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_065257"
FT   VARIANT         270
FT                   /note="I -> T (in dbSNP:rs2230281)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_019576"
FT   VARIANT         506
FT                   /note="V -> I (in dbSNP:rs2230283)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:9804815"
FT                   /id="VAR_019577"
FT   MUTAGEN         459
FT                   /note="D->H: Affects the glycopeptide specificity and
FT                   abolishes ability to glycosylate Muc1, Muc2 and Muc5AC."
FT                   /evidence="ECO:0000269|PubMed:10984485"
FT   CONFLICT        11
FT                   /note="S -> T (in Ref. 1; CAA69875)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="D -> Y (in Ref. 1; CAA69875)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="D -> Y (in Ref. 1; CAA69875)"
FT                   /evidence="ECO:0000305"
FT   STRAND          62..64
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           76..78
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           87..100
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           104..107
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           122..125
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   TURN            131..133
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          137..145
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           148..161
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   TURN            164..166
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          167..174
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           180..182
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           184..191
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          196..200
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           207..217
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          220..225
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          228..232
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           237..246
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          250..259
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   TURN            261..263
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          275..278
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          284..287
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           291..296
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          314..317
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           318..323
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           329..331
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          333..335
FT                   /evidence="ECO:0007829|PDB:5NQA"
FT   HELIX           338..347
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          351..363
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           376..386
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           388..390
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           391..397
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           399..403
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           410..418
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           424..430
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          444..451
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   TURN            452..455
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          456..459
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          464..466
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          473..476
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           482..484
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          486..488
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          494..496
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          498..500
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          502..505
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          514..517
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           527..529
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          539..541
FT                   /evidence="ECO:0007829|PDB:5NQA"
FT   TURN            542..544
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          547..552
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          558..564
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          567..569
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   HELIX           570..572
FT                   /evidence="ECO:0007829|PDB:6H0B"
FT   STRAND          574..577
FT                   /evidence="ECO:0007829|PDB:6H0B"
SQ   SEQUENCE   578 AA;  66666 MW;  6EEEF502A40CBD2E CRC64;
     MAVRWTWAGK SCLLLAFLTV AYIFVELLVS TFHASAGAGR ARELGSRRLS DLQKNTEDLS
     RPLYKKPPAD SRALGEWGKA SKLQLNEDEL KQQEELIERY AINIYLSDRI SLHRHIEDKR
     MYECKSQKFN YRTLPTTSVI IAFYNEAWST LLRTIHSVLE TSPAVLLKEI ILVDDLSDRV
     YLKTQLETYI SNLDRVRLIR TNKREGLVRA RLIGATFATG DVLTFLDCHC ECNSGWLEPL
     LERIGRDETA VVCPVIDTID WNTFEFYMQI GEPMIGGFDW RLTFQWHSVP KQERDRRISR
     IDPIRSPTMA GGLFAVSKKY FQYLGTYDTG MEVWGGENLE LSFRVWQCGG KLEIHPCSHV
     GHVFPKRAPY ARPNFLQNTA RAAEVWMDEY KEHFYNRNPP ARKEAYGDIS ERKLLRERLR
     CKSFDWYLKN VFPNLHVPED RPGWHGAIRS RGISSECLDY NSPDNNPTGA NLSLFGCHGQ
     GGNQFFEYTS NKEIRFNSVT ELCAEVPEQK NYVGMQNCPK DGFPVPANII WHFKEDGTIF
     HPHSGLCLSA YRTPEGRPDV QMRTCDALDK NQIWSFEK
//
